[HTML][HTML] Convalescent plasma for the prevention and treatment of COVID-19: a systematic review and quantitative analysis
Background: The COVID-19 pandemic, caused by a novel coronavirus termed SARS-CoV-2,
has spread quickly worldwide. Convalescent plasma (CP) obtained from patients following …
has spread quickly worldwide. Convalescent plasma (CP) obtained from patients following …
Convalescent plasma therapy for management of COVID-19: Perspectives and deployment in the current global pandemic
The world is striving against the severe crisis of the COVID-19 pandemic. Healthcare
professionals are struggling to treat their patients based on nonspecific therapies. Amidst …
professionals are struggling to treat their patients based on nonspecific therapies. Amidst …
Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program
Abstract Background Coronavirus disease 2019 (COVID‐19) convalescent plasma (CCP)
collection began in two Brazilian hospitals for treatment of severe/critical patients. Methods …
collection began in two Brazilian hospitals for treatment of severe/critical patients. Methods …
Guidance for the procurement of COVID‐19 convalescent plasma: differences between high‐and low‐middle‐income countries
Background and objectives COVID‐19 convalescent plasma (CCP) has been used,
predominantly in high‐income countries (HICs) to treat COVID‐19; available data suggest …
predominantly in high‐income countries (HICs) to treat COVID‐19; available data suggest …
International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID‐19 pandemic
Abstract Background and Objectives The coronavirus disease 2019 (COVID‐19) pandemic
has impacted blood systems worldwide. Challenges included maintaining blood supplies …
has impacted blood systems worldwide. Challenges included maintaining blood supplies …
A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and …
S Wendel, R Fontão‐Wendel, R Fachini… - …, 2021 - Wiley Online Library
Introduction Little is known about the neutralizing (nAb) and binding antibody kinetics in
COVID‐19 convalescent plasma donors, especially during the first 100 days after disease …
COVID‐19 convalescent plasma donors, especially during the first 100 days after disease …
Research initiatives of blood services worldwide in response to the covid‐19 pandemic
SF O'Brien, RW Lieshout‐Krikke, A Lewin… - Vox …, 2021 - Wiley Online Library
Background and Objectives While coronavirus (COVID‐19) is not transfusion‐transmitted,
the impact of the global pandemic on blood services worldwide is complex. Convalescent …
the impact of the global pandemic on blood services worldwide is complex. Convalescent …
COVID‐19 and the impact on blood availability and transfusion practices in low‐and middle‐income countries
Abstract Background/Case Studies The coronavirus disease 2019 (COVID‐19) pandemic
disrupted the global blood supply. Low‐and middle‐income countries (LMICs) already …
disrupted the global blood supply. Low‐and middle‐income countries (LMICs) already …
SARS-CoV-2 pandemic and food safety oversight: Implications in Canada and coping strategies
S Charlebois, J Music - Foods, 2021 - mdpi.com
The SARS-CoV-2 pandemic has created enormous societal disruptions in the Western
world, including Canada, with serious implications for food safety. Since the start of the …
world, including Canada, with serious implications for food safety. Since the start of the …
Lessons learned in the collection of convalescent plasma during the COVID‐19 pandemic
Background The lack of definitive treatment or preventative options for COVID‐19 led many
clinicians early on to consider convalescent plasma (CCP) as potentially therapeutic …
clinicians early on to consider convalescent plasma (CCP) as potentially therapeutic …